+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Brexpiprazole"

From
Post-traumatic Stress Disorder (PTSD) - Pipeline Insight, 2024 - Product Thumbnail Image

Post-traumatic Stress Disorder (PTSD) - Pipeline Insight, 2024

  • Clinical Trials
  • February 2024
  • 80 Pages
  • Global
From
REXULTI Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

REXULTI Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • July 2023
  • 30 Pages
  • Global
From
US Depression Drugs Market, Dosage, Price, Sales Insight 2021-2026 - Product Thumbnail Image

US Depression Drugs Market, Dosage, Price, Sales Insight 2021-2026

  • Report
  • February 2021
  • 420 Pages
  • United States
From
From
United States VRAYLAR Market Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

United States VRAYLAR Market Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • January 2023
  • 30 Pages
  • United States
From
From
Rexulti (brexpiprazole) Drug Overview 2019 - Product Thumbnail Image

Rexulti (brexpiprazole) Drug Overview 2019

  • Report
  • March 2019
  • 33 Pages
  • Global
From
  • 12 Results (Page 1 of 1)
Loading Indicator

Brexpiprazole is a medication used to treat mental disorders such as schizophrenia, major depressive disorder, and bipolar disorder. It is a serotonin-dopamine activity modulator (SDAM) that works by balancing the levels of serotonin and dopamine in the brain. Brexpiprazole is a relatively new drug, having been approved by the FDA in 2015. It is available in both oral and injectable forms. Brexpiprazole is generally well-tolerated and has fewer side effects than other antipsychotic medications. It is also effective in treating symptoms of depression and anxiety. Brexpiprazole is often used as an adjunct to other medications, such as antidepressants, to help improve overall mental health. The brexpiprazole market is growing as more people are being diagnosed with mental disorders and seeking treatment. It is becoming increasingly popular as a treatment option due to its effectiveness and low side effect profile. Some companies in the brexpiprazole market include Otsuka Pharmaceuticals, Lundbeck, and Allergan. Show Less Read more